David Schnell

Fundador en

Prospect Venture Partners

66 años

82 relaciones

Health Technology

Consumer Services

Finance

Perfil

David Schnell is the founder and currently holds the position of Managing Director at Prospect Venture Partners, a company he founded in 1997.
He is also currently the Director at Panmira Pharmaceuticals LLC and the Managing Director at Iconica LLC.
In the past, Dr. Schnell has held positions as Director at Neurocrine Biosciences, Inc., Essential Therapeutics, Inc., Emdeon Corp., Senomyx, Inc., Emergent Product Development Seattle, Gloucester Pharmaceuticals, Inc., Satori Pharmaceuticals, Inc., Amira Pharmaceuticals, Inc., Kythera Biopharmaceuticals LLC, Lux Biosciences, Inc., Alvine Pharmaceuticals, Inc., NGM Biopharmaceuticals, Inc., Trine Pharmaceuticals, Inc., Rinat Neuroscience Corp., Nora Therapeutics, Inc., Healtheon, Inc., Microcide, Inc., and Sandoz Pharmaceuticals Corp.
Dr. Schnell's education includes an undergraduate degree from Stanford University in 1982, a doctorate from Harvard Medical School in 1987, and a graduate degree from Stanford University School of Medicine in 1982.

Cargos activos de David Schnell

Empresas	Cargo	Inicio
Prospect Venture Partners Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and biomedical innovation sectors. It provides financing for seed, early and growth stage capital requirements.	Fundador	01/01/1997
Panmira Pharmaceuticals LLC Panmira Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug development programs for inflammatory diseases	Director/Miembro de la Junta	-
Iconica LLC Iconica LLC Investment ManagersFinance Iconica Partners invests in companies located in the United States. The firm targets companies operating in the fields of sports, media, entertainment and technology. It provides financing for seed and early stage capital requirements.	Inversor de Capital Privado	-

Todos los cargos activos de David Schnell

Antiguos cargos conocidos de David Schnell.

Empresas	Cargo	Fin
NGM BIOPHARMACEUTICALS, INC.	Director/Miembro de la Junta	08/06/2021
KYTHERA BIOPHARMACEUTICALS INC	Director/Miembro de la Junta	31/12/2014
Gloucester Pharmaceuticals, Inc. Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients	Director/Miembro de la Junta	26/04/2011
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products	Director/Miembro de la Junta	28/10/2010
Trine Pharmaceuticals, Inc. Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products	Director/Miembro de la Junta	19/09/2008

Ver el detalle de la experiencia de David Schnell.

Formación de David Schnell.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de David Schnell.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	25
Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders	Health Technology
Essential Therapeutics, Inc. Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical goods for viral and fungal infections	Health Technology
Emdeon Corp. Emdeon Corp. Data Processing ServicesTechnology Services Develops Internet-based information and transaction processing of health care information systems	Technology Services
Senomyx, Inc. Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Discovers and develops novel flavors and taste modulators for the packaged food and beverage industry	Consumer Non-Durables
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products	Health Technology
Gloucester Pharmaceuticals, Inc. Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients	Health Technology
Satori Pharmaceuticals, Inc. Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease	Health Technology
Amira Pharmaceuticals, Inc. Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products	Health Technology
Kythera Biopharmaceuticals LLC Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes novel dermatology prescription drugs	Health Technology
Lux Biosciences, Inc. Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat ophthalmic diseases	Health Technology
Alvine Pharmaceuticals, Inc. Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases	Health Technology
NGM Biopharmaceuticals, Inc. NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines	Health Technology
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kleiner Perkins Caufield & Byers LLC Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers invests in companies located in the United States. The firm targets companies operating in consumer, enterprise, Fintech, hardtech and healthcare sectors. It provides financing for seed, early, and later stage capital requirements.	Finance
Prospect Venture Partners Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and biomedical innovation sectors. It provides financing for seed, early and growth stage capital requirements.	Finance
Trine Pharmaceuticals, Inc. Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products	Health Technology
Rinat Neuroscience Corp. Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases	Health Technology
Sandoz Pharmaceuticals Corp.
Nora Therapeutics, Inc. Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments for infertility and miscarriages	Health Technology
Healtheon, Inc. Healtheon, Inc. Medical/Nursing ServicesHealth Services Provides medical diagnostic and information technology services	Health Services
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Panmira Pharmaceuticals LLC Panmira Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug development programs for inflammatory diseases	Health Technology
Stanford University School of Medicine Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Iconica LLC Iconica LLC Investment ManagersFinance Iconica Partners invests in companies located in the United States. The firm targets companies operating in the fields of sports, media, entertainment and technology. It provides financing for seed and early stage capital requirements.	Finance
Microcide, Inc. Microcide, Inc. BiotechnologyHealth Technology Biotechnology company that develops nontoxic antimicrobial products	Health Technology